Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPARLISIB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where BUPARLISIB was used for B-cell lymphoma.

Most Reported Side Effects for BUPARLISIB

Side Effect Reports % Deaths Hosp.
Hyperglycaemia 13 13.7% 0 3
Diarrhoea 11 11.6% 0 4
Alanine aminotransferase increased 10 10.5% 0 0
Depression 10 10.5% 0 1
Product use in unapproved indication 10 10.5% 3 9
Anxiety 9 9.5% 0 1
Asthenia 8 8.4% 0 4
Fatigue 8 8.4% 0 3
Rash 8 8.4% 0 1
Nausea 7 7.4% 0 2
Aspartate aminotransferase increased 6 6.3% 0 0
Mucosal inflammation 6 6.3% 2 3
Neutropenia 6 6.3% 1 1
Rash maculo-papular 6 6.3% 1 1
Anaemia 5 5.3% 0 1

Other Indications for BUPARLISIB

Breast cancer metastatic (16) Basal cell carcinoma (6) Her-2 positive breast cancer (6) Squamous cell carcinoma of head and neck (6) Neoplasm malignant (5)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

BUPARLISIB Full Profile All B-cell lymphoma Drugs BUPARLISIB Demographics BUPARLISIB Timeline